Latest / Bloomberg Intelligence
Lilly Falls as Weight-Loss Pill Data Overshadows Sales Beat
Watch Paul LIVE every day on YouTube: http://bit.ly/3vTiACF.
Bloomberg Intelligence hosted by Paul Sweeney and Lisa Mateo
- Damian Garde, Bloomberg News Health Reporter, discusses the latest on Eli Lilly. Eli Lilly shares tumbled as disappointing data on its new weight-loss pill overshadowed strong growth from the company’s current obesity medicine, which helped drive it to raise its yearly profit and sales outlook.
- Geetha Ranganathan, Bloomberg Intelligence Analyst on US Media, discusses earnings from Warner Brothers Discovery and Peloton. Warner Bros. Discovery Inc., the parent of…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.